Aurélie Thedrez - Concepedia

Author

Aurélie Thedrez

Inserm ORCID

Also Known As

A Thedrez, A. Thedrez, A. Thédrez, Aurelie Thedrez, Aurélie Thedrez, Aurélie Thédrez, Thedrez Aurelie, Thedrez, Aurélie

Publications

941

Citations

H-Index

Concepts

All Affiliations

Inserm Nantes Université PhysioPathologie des Adaptations Nutritionnelles Centre National de la Recherche Scientifique Centre Hospitalier Universitaire de La Réunion

About

Aurélie Thedrez is an author at Inserm specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	167
2	Cell Biology	3	3	56
3	Public Health	1	1	68
4	Biostatistics	1	1	68
5	Diabetes	1	1	31

Aurélie Thedrez

Publications

625

Citations

H-Index

Page 1

	Year	Citations
PCSK9 Modulates the Secretion But Not the Cellular Uptake of Lipoprotein(a) Ex Vivo Elise F. Villard, Aurélie Thedrez, Jörg Blankenstein, JACC Basic to Translational Science	2016	116
Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor) Aurélie Thedrez, Dirk Blom, Stéphane Ramin‐Mangata, Arteriosclerosis Thrombosis and Vascular Biology	2017	102
PCSK9 and lipoprotein (a) levels are two predictors of coronary artery calcification in asymptomatic patients with familial hypercholesterolemia Rodrigo Alonso, Pedro Mata, Ovidio Muñiz-Grijalvo, Atherosclerosis Metabolic SyndromeFamilial HypercholesterolemiaVascular DiseaseCardiovascular DiseaseGenetic Epidemiology	2016	68
IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human Vγ9Vδ2 T Cells for Adoptive Immunotherapy Aurélie Thedrez, Christelle Harly, Alexis Morice, The Journal of Immunology	2009	65
CD4 engagement by CD1d potentiates activation of CD4+ invariant NKT cells Aurélie Thedrez, Claudia de Lalla, Sophie Allain‐Maillet, Blood	2007	57
PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate Mikaël Croyal, Thi-Thu-Trang Tran, Rose Hélène Blanchard, Clinical Science	2018	48
Circulating PCSK9 levels are not associated with the conversion to type 2 diabetes Stéphane Ramin‐Mangata, Matthieu Wargny, Matthieu Pichelin, Atherosclerosis Metabolic SyndromePcsk9 LevelsInsulin ManagementDiabetesGenetic Epidemiology	2019	31
Effects of proprotein convertase subtilisin kexin type 9 modulation in human pancreatic beta cells function Stéphane Ramin‐Mangata, Aurélie Thedrez, Brice Nativel, Atherosclerosis Signal TransductionMolecular PhysiologyPhysiologyPancreas TransplantationMedicine	2021	25
Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia—Brief Report Aurélie Thedrez, Barbara Sjouke, Maxime Passard, Arteriosclerosis Thrombosis and Vascular Biology	2016	22
Identification of a Gain-of-Function <i>LIPC</i> Variant as a Novel Cause of Familial Combined Hypocholesterolemia Wieneke Dijk, Mathilde Di Filippo, Sander Kooijman, Circulation	2022	20

Page 1